Oral health care formulation and method of preparation for the same are disclosed herein. The disclosed oral care composition includes a combination of various herbs and minerals, and may be used to maintain good oral hygiene. Further, a method of oral health care is also disclosed in the various embodiments herein.

Oral health care formulation and method of preparation for the same are disclosed herein. The disclosed oral care composition includes a combination of various herbs and minerals, and may be used to maintain good oral hygiene. Further, a method of oral health care is also disclosed in the various embodiments herein.

Oral health care formulation and method of preparation for the same are disclosed herein. The disclosed oral care composition includes a combination of various herbs and minerals, and may be used to maintain good oral hygiene. Further, a method of oral health care is also disclosed in the various embodiments herein.

Provided is a novel functional composition having an excellent beneficial effect on memory-learning ability that can also be utilized in the form of a food or beverage, etc. Phosphatidylinositol is used as an active ingredient of an oral composition for improving memory-learning ability. The phosphatidylinositol is preferably derived from soybeans. This composition can be used suitably in the form of a food or beverage, food additive, pharmaceutical, supplement, animal feed, etc.

Provided is a novel functional composition having an excellent beneficial effect on memory-learning ability that can also be utilized in the form of a food or beverage, etc. Phosphatidylinositol is used as an active ingredient of an oral composition for improving memory-learning ability. The phosphatidylinositol is preferably derived from soybeans. This composition can be used suitably in the form of a food or beverage, food additive, pharmaceutical, supplement, animal feed, etc.

The present disclosure relates the methods and compositions for preventing the recurrence of a cancer in mammals and enhance efficacy of cancer immunotherapies. The compositions used in the method include an herbal extract YIV-906, which comprises herbal extracts of Scutellaria baicalensis (S), Glycyrrhiza uralensis (G), Paeonia lactiflora (P), and Ziziphus jujuba (Z), or β-glucuronidase treated YIV-906 (YIV-906GU).

The present disclosure relates the methods and compositions for preventing the recurrence of a cancer in mammals and enhance efficacy of cancer immunotherapies. The compositions used in the method include an herbal extract YIV-906, which comprises herbal extracts of Scutellaria baicalensis (S), Glycyrrhiza uralensis (G), Paeonia lactiflora (P), and Ziziphus jujuba (Z), or β-glucuronidase treated YIV-906 (YIV-906GU).

The present disclosure relates the methods and compositions for preventing the recurrence of a cancer in mammals and enhance efficacy of cancer immunotherapies. The compositions used in the method include an herbal extract YIV-906, which comprises herbal extracts of Scutellaria baicalensis (S), Glycyrrhiza uralensis (G), Paeonia lactiflora (P), and Ziziphus jujuba (Z), or β-glucuronidase treated YIV-906 (YIV-906GU).

An application of a traditional Chinese medicine composition in preparing a medicine for treating or preventing coronavirus infection. The traditional Chinese medicine composition is characterized by being prepared from the following raw materials in parts by weight: 5-15 parts of Cornu saigae tataricae or 50-150 parts of goral horns, 10-60 parts of Bulbus Fritillariae Ussuriensis, 15-60 parts of Radix et Rhizoma Rhei, 7-30 parts of Radix scutellariae, 7-30 parts of Lapis Chloriti, 10-50 parts of gypsum fibrosum, 5-20 parts of calculus bovis artifactus, and 15-60 parts of radix glycyrrhizae. The traditional Chinese medicine composition can inhibit 2019-nCoV replication in cells, so that cells infected by 2019-nCoV viruses have no lesion. Therefore, the traditional Chinese medicine composition can treat or prevent coronavirus related diseases.

An application of a traditional Chinese medicine composition in preparing a medicine for treating or preventing coronavirus infection. The traditional Chinese medicine composition is characterized by being prepared from the following raw materials in parts by weight: 5-15 parts of Cornu saigae tataricae or 50-150 parts of goral horns, 10-60 parts of Bulbus Fritillariae Ussuriensis, 15-60 parts of Radix et Rhizoma Rhei, 7-30 parts of Radix scutellariae, 7-30 parts of Lapis Chloriti, 10-50 parts of gypsum fibrosum, 5-20 parts of calculus bovis artifactus, and 15-60 parts of radix glycyrrhizae. The traditional Chinese medicine composition can inhibit 2019-nCoV replication in cells, so that cells infected by 2019-nCoV viruses have no lesion. Therefore, the traditional Chinese medicine composition can treat or prevent coronavirus related diseases.